American International Group, Inc. Unity Biotechnology, Inc. Transaction History

American International Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$4.15 - $6.3 $85,701 - $130,101	-20,651 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$5.51 - $9.42 $303 - $518	55 Added 0.27%	20,651 $124,000
Q4 2020 Feb 12, 2021	SELL	$3.42 - $6.36 $827 - $1,539	-242 Reduced 1.16%	20,596 $108,000
Q3 2020 Nov 04, 2020	BUY	$2.94 - $12.43 $2,096 - $8,862	713 Added 3.54%	20,838 $72,000
Q2 2020 Aug 12, 2020	BUY	$5.28 - $9.67 $16,943 - $31,031	3,209 Added 18.97%	20,125 $175,000
Q1 2020 May 04, 2020	SELL	$5.0 - $7.6 $4,890 - $7,432	-978 Reduced 5.47%	16,916 $98,000
Q4 2019 Feb 05, 2020	BUY	$5.99 - $8.38 $6,235 - $8,723	1,041 Added 6.18%	17,894 $129,000
Q3 2019 Nov 08, 2019	SELL	$5.62 - $9.63 $657 - $1,126	-117 Reduced 0.69%	16,853 $103,000
Q2 2019 Aug 13, 2019	BUY	$7.59 - $10.21 $8,341 - $11,220	1,099 Added 6.92%	16,970 $161,000
Q1 2019 May 06, 2019	SELL	$7.65 - $16.66 $3,939 - $8,579	-515 Reduced 3.14%	15,871 $129,000
Q4 2018 Feb 13, 2019	BUY	$10.76 - $17.25 $140,288 - $224,905	13,038 Added 389.43%	16,386 $266,000
Q3 2018 Nov 09, 2018	BUY	$14.34 - $22.97 $860 - $1,378	60 Added 1.82%	3,348 $55,000
Q2 2018 Aug 08, 2018	BUY	$12.76 - $16.94 $41,954 - $55,698	3,288 New	3,288 $50,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $17M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.